Potentiates vaccine for
Innovative technology for novel vaccine
Cold chain free nasal vaccine
Peptide vaccine without pathogen
Low cost T Cell therapy for cancer
and infectious disease
Dongho Kim, Ph.D. CEOPh.D. University of Texas at Austin
Postdoc. in Beckman Research Institute of City of Hope
Staff Scientist/Director of RNAi core of Beckman Research Institute of COH
CEO and Founder of Cellonex, Biofactories, Genolution, IRI Pharma, NA Vaccine Institute
Adjunct Professor, POSTECH
Myung-soo Kang, Ph.D. COOSeoul National University
Instructor at Harvard Medical School
Professor at Samsung Medical Center
Director at Intron Biotechnology
Eui Ho Kim, Ph.D. CTOPh.D. University of Wisconsin-Madison, Immunology
Postdoc. Emory University, Vaccine immunology
Research Fellow at NIEHS, National Institutes of Health
John Rossi, Ph.D.Board director of scientific advisory
Chair and Professor, Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope.
A World Leader in RNAi and in clinical research with nucleic acids.
Co-founder of Dicerna Pharmaceuticals, Calando Pharmaceuticals, Inc.
John Killmer, Ph.D.Vice president: strategic alliance
Specialty in clinical trials. 30 years in biotechnology industries including 25 years with Monsanto. P&L, R&D and product management as President of Monsanto China.
Won Jong Kim, Ph.D.Scientific Advisor Ph.D.
Tokyo Institute of Technology Postdoc. in University of Utah Mueunjae Chaired Professor, POSTECH
Soolim OhVice President: marketing and HR
A marketing specialist in biotech.
Served in BMS Korea for 28 years and made it from a new company to about $300 million sales groups.
Served CEO and VP for more than 5 companies in the groups.
Taerim Yun, CFOSungkyunkwan University, MBA
SK Telecom Team Leader , SK Planet Project Leader
Specialist in Finance, M&A, Venture Fund Investment, Business Portfolio Management